Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

PauseRX vs Enhance MD

Name: PauseRX
Brand: PauseRX
Price: 199 USD
Availability: InStock

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

6.5

PauseRX

Best for explicit 503A pharmacy and physician-network disclosure

★★★☆☆3.3

Starting at $199/mo

BrandSemaglutideTirzepatideWegovy

Visit PauseRX →

8.6

Enhance MD

Best for lab-monitored compounded GLP-1 with mandatory video visit

★★★★☆4.3

Starting at $49/mo

CompoundedSemaglutideTirzepatideVideo Visit

Visit Enhance MD →

Side-by-Side Comparison

Feature	PauseRX	Enhance MD
Overall Score	6.5/10	✓8.6/10
Starting Price	$199/mo	✓$49/mo
Editorial Rating	3.3 ★ /5	✓4.3 ★ /5
Features	✓8 features	6 features
States Available	0	✓39
Compounded	✓ Yes	✓ Yes
Brand Name	—	—
FSA/HSA Accepted	—	—
FDA Warnings	None	None

Pros & Cons

PauseRX

Pros

✓Names its 503A pharmacy partner (Strive Pharmacy, Gilbert AZ) — buyers can independently verify its licensure
✓Names its physician network (Beluga Health) — you can research the clinical platform handling your prescriptions
✓Publishes the FDA compounded-medication disclaimer
✓Corporate legal entity disclosed (PauseRX, Inc.) — uncommon for direct-to-consumer GLP-1 platforms
✓Flat $199 'all doses' compounded semaglutide pricing — no per-tier escalation
✓Billed at ship, not at order — lower upfront cash exposure
✓LegitScript badge displayed
✓Adjunct longevity products (NAD+, Glutathione, Sermorelin) for a broader wellness stack

Cons

✗States served not listed — site claims nationwide, but you must contact support to confirm availability
✗Restrictive cancellation policy — orders can't be changed or canceled once submitted, and medications can't be returned
✗No named medical director (Beluga Health is the network, not a named MD)
✗LegitScript certification number not shown — badge only, so no direct lookup
✗Insurance not accepted — cash-pay only; HSA/FSA eligibility not confirmed
✗Corporate physical address not provided
✗Despite the 'Pause' name, not positioned as menopause-specific care
✗Brand Wegovy, Zepbound, and Foundayo are consultations only, not direct dispensing

Enhance MD

Pros

✓Baseline and ongoing metabolic labs (CMP, lipids, TSH, HbA1c) at Quest every 6 months — rare for compounded GLP-1
✓Mandatory video visit with a US-licensed MD or NP before your first prescription — not a pure questionnaire model
✓Three tiers, including a combined semaglutide + tirzepatide Elite plan ($322/mo) for patients plateaued on one GLP-1
✓Uses LegitScript-certified 503A pharmacies (Tru Meds Rx, Strive Pharmacy, Pharmacy Hub)
✓Low first-month intro pricing: $49 Core, $99 Advanced, $189 Elite
✓Unlimited clinician messaging and dose-adjustment support included

Cons

✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
✗Not available in 10 states: AL, AR, GA, HI, LA, MS, MO, SC, TN, WV
✗Mandatory lab work adds 5–10 days to onboarding vs async-only competitors
✗No insurance accepted — cash pay, HSA/FSA eligible
✗Intro pricing resets to full tier rate after 30 days — the $49/$99/$189 figures aren't ongoing cost

Our Verdict

Winner: Enhance MDScore: 8.6/10

Enhance MD edges out PauseRX with a higher overall score of 8.6/10 and is particularly strong for lab-monitored compounded GLP-1 with mandatory video visit. PauseRX remains a solid alternative, especially if you're looking for explicit 503A pharmacy and physician-network disclosure.

Get Started with PauseRX →Get Started with Enhance MD →

Glossary references

Key terms in this article, linked to their canonical definitions.

Semaglutide · Drugs and brands
Tirzepatide · Drugs and brands
Compounded GLP-1 · Pharmacy and drug forms
503A pharmacy · Pharmacy and drug forms
PCAB accreditation · Pharmacy and drug forms
Prior authorization (PA) · Insurance and regulatory
Off-label use · Insurance and regulatory
FDA Drug Shortage List · Insurance and regulatory

Related comparisons

Continue exploring PauseRX and Enhance MD head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.